Data set of interactomes and metabolic pathways of proteins differentially expressed in brains with Alzheimer׳s disease

Alzheimer׳s disease is one of the main causes of dementia in the elderly and its frequency is on the rise worldwide. It is considered the result of complex interactions between genetic and environmental factors, being many of them unknown. Therefore, there is a dire necessity for the identification...

Full description

Saved in:
Bibliographic Details
Published inData in brief Vol. 7; pp. 1707 - 1719
Main Authors Minjarez, Benito, Calderón-González, Karla Grisel, Valero Rustarazo, Ma Luz, Herrera-Aguirre, María Esther, Labra-Barrios, María Luisa, Rincon-Limas, Diego E., Sánchez del Pino, Manuel M., Mena, Raul, Luna-Arias, Juan Pedro
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.06.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer׳s disease is one of the main causes of dementia in the elderly and its frequency is on the rise worldwide. It is considered the result of complex interactions between genetic and environmental factors, being many of them unknown. Therefore, there is a dire necessity for the identification of novel molecular players for the understanding of this disease. In this data article we determined the protein expression profiles of whole protein extracts from cortex regions of brains from patients with Alzheimer׳s disease in comparison to a normal brain. We identified 721 iTRAQ-labeled polypeptides with more than 95% in confidence. We analyzed all proteins that changed in their expression level and located them in the KEGG metabolic pathways, as well as in the mitochondrial complexes of the electron transport chain and ATP synthase. In addition, we analyzed the over- and sub-expressed polypeptides through IPA software, specifically Core I and Biomarkers I modules. Data in this article is related to the research article “Identification of proteins that are differentially expressed in brains with Alzheimer’s disease using iTRAQ labeling and tandem mass spectrometry” (Minjarez et al., 2016) [1].
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Deceased.
ISSN:2352-3409
2352-3409
DOI:10.1016/j.dib.2016.04.071